[06.10.2023] Content error, AnKing Overhaul for Step 1 & 2/AnKingMed, ID 482592

Suggestions Change Note Suggestions
,
1

View Suggestion on AnkiHub

1 Like
2

I agree with the recommendation for the Text field with one small stylistic caveat. In the interest of concise, short answers I would recommend changing the cloze as such:
{{c1::Premedication with an ICS and β-agonist (budesonide-formoterol) 10 minutes prior to exercise}} —> {{c1::ICS-LABA 10 min prior to exercise}}
Regarding the Extra and Lecture Notes fields:

  1. I am confused by your suggestion for the Lecture Notes field. It seems this may be a personal reminder you made that just got pulled in automatically with the rest of the suggested change.
  2. I feel this qualifies as a major change and requires the following to be added to the Extra field:
    ‘This card previously stated “Short-acting β-agonists 10-20 minutes before exercise”, however, AMBOSS and UWorld (QID: 3050) confirm ICS-LABA 10 minutes prior to exercise for exercise-induced bronchoconstriction is the preferred treatment. (Dec 2023)’
  3. It seems the Extra field is also in need of editing here, I would recommend the first line of Extra field be changed:
    “use ICS + LABA or anti-leukotriene if exercising daily” —> “ICS-LABA (eg. budesonide-formotero) is first line treatment, refractory symptoms or frequent/prolonged exercise may be require management with daily ICS-LABA or leukotriene receptor antagonist.”
3

These are just my suggestions, it is the maintainers that actually make the final decision.

@herstein.jacob @Cameron @shmuelsash @Sameem @StanG @zarathustra @Tahseen @Bilal @Morgankota13 @thomas.holmes

4

@Ahmed7

5

Need to be careful with changes since there is a sister card (nid:1496188470679)

6

So the sister card (nid: 1496188470679) is regarding treatment with daily exercise, which I think should be referenced in the Extra field of this note. However, after looking at that card more closely, it will also need some small amount of revision.

7

This treatment is based on GINA guidelines which is cited by UWorld.

GINA 2021 and 2023: As-needed budesonide-formoterol improves asthma control by reducing exercise-induced bronchoconstriction in the same order of magnitude as daily budesonide despite a substantially lower total steroid dose.

Somebody please look up NAEPP guidelines as shelf exams mostly use that.

I would personally go with GINA.